Serotonin Syndrome Following Septal Myectomy in Association With Fentanyl and Methylene Blue: A Case Report

Psychosomatics

Volumn 59, Issue 5, 2018, Pages 512-516

  Haacker, Lindsay ^a   Maliekel, MaryJo ^a   Bardsley, Christina E Hantsch ^b   Bergren, Ryan ^b   Meresh, Edwin ^b   Halaris, Angelos ^b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ENOXAPARIN; FENTANYL; FENUGREEK EXTRACT; LISDEXAMFETAMINE; METHYLENE BLUE; METOPROLOL; PAROXETINE; INTRAVENOUS ANESTHETIC AGENT; VASOCONSTRICTOR AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; CLINICAL ARTICLE; CONSULTATION; DELIRIUM; DEPRESSION; DISEASE DURATION; DRUG SUBSTITUTION; DRUG THERAPY; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; FATIGUE; FENUGREEK; GENERAL CONDITION DETERIORATION; GINSENG; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART MURMUR; HEART MUSCLE CONTRACTILITY; HERBAL MEDICINE; HOSPITAL ADMISSION; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; MEDICAL HISTORY; MUSCLE RESECTION; PATIENT TRANSPORT; POSTOPERATIVE COMPLICATION; SEROTONIN SYNDROME; THORAX SURGERY; TRANSTHORACIC ECHOCARDIOGRAPHY; VASCULAR RESISTANCE; GENERAL ANESTHESIA; HEART SEPTUM; HEART VALVE REPLACEMENT; SURGERY;

ADULT; ANESTHESIA, GENERAL; ANESTHETICS, INTRAVENOUS; FENTANYL; HEART SEPTUM; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; METHYLENE BLUE; SEROTONIN SYNDROME; VASOCONSTRICTOR AGENTS;

EID: 85044105112     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2018.02.001     Document Type: Article

References (19)

1. Dvir, Y., Smallwood, P., Serotonin syndrome: a complex but easily avoidable condition. Gen Hosp Psychiatry 30 (2007), 284–287.
2. Wang, R., Vashistha, V., Sukhdeep, K., Houchens, N., Serotonin syndrome: preventing, recognizing, and treating it. Cleve Clin J Med 83 (2016), 810–817.
3. Schumacher, L.E.D., Blumer, V., Chaparro, S.V., Methylene blue-induced serotonin syndrome after left ventricular assist device implantation: a case report and literature review. J Thorac Cardiovasc Surg 154 (2017), e39–e43.
4. Shanmugam, G., Kent, B., Baskett, R., Serotonin syndrome following cardiac surgery. Interact Cardiovasc Thorac Surg 7 (2008), 656–657.
5. Koury, K.M., Tsui, B., Gulur, P., Incidence of serotonin syndrome in patients treated with fentanyl on serotonergic agents. Pain Physician 18 (2015), e27–e30.
6. Kapadia, K., Cheung, F., Lee, W., Thalappillil, R., Florence, F.R., Kim, J., Methylene blue causing serotonin syndrome following cystocele repair. Urol Case Rep 9 (2016), 15–17.
7. Gillman, P.K., Methylene blue and serotonin toxicity: definite causal link. Psychosomatics 51:5 (2010), 448–449.
8. Ng, B.K., Cameron, A.J., The role of methylene blue in serotonin syndrome: a systematic review. Psychosomatics 51 (2010), 194–200.
9. Ailawadhi, S., Sung, K.W., Carlson, L.A., Baer, M.R., Serotonin syndrome caused by interaction between citalopram and fentanyl. J Clin Pharm Ther 32 (2007), 199–202.
10. Francescangeli, J., Vaida, S., Bonavia, A.S., Perioperative diagnosis and treatment of serotonin syndrome following administration of methylene blue. Am J Case Rep 17 (2016), 347–351.
11. Dunkley, E.J., Isbister, G.K., Sibbritt, D., Dawson, A.H., Whyte, I.M., The Hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM 96:9 (2003), 635–642.
12. Boyer, E.W., Shannon, M., The serotonin syndrome. N Engl J Med 352 (2005), 1112–1120.
13. Ables, A.Z., Nagubilli, R., Prevention, diagnosis, and management of serotonin syndrome. Am Fam Physician 81:9 (2010), 1139–1142.
14. Preskorn, S.H., Clinically relevant pharmacology of selective serotonin reuptake inhibitors: an overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism. Clin Pharmacokinet 32 (1997), 1–21.
15. Smith, P., Attix, D.K., Weldon, B.C., Monk, T.G., Depressive symptoms and risk of postoperative delirium. Am J Geriatr Psychiatry 24:3 (2016), 232–238.
16. Lonergan, E., Britton, A.M., Luxenberg, J., Wylier, T., Antipsychotics for delirium. Cochrane Database Syst Rev, 18(2), 2007, CD005594 PMID:17443602 http://dx.doi.org/10.1002/14651858.CD005594.pub2.
17. Verre, M., Bossio, F., Mammonie, A., et al. Serotonin syndrome caused by olanzapine and clomipramine. Minerva Anestesiol 74:1–2 (2008), 41–45.
18. Haslett, C.D., Kumar, S., Can olanzapine be implicated in causing serotonin syndrome?. Psychiatry Clin Neurosci 56 (2002), 533–535.
19. Boddy, R., Ali, R., Dowsett, R., Use of sublingual olanzapine in serotonin syndrome. J Toxicol Clin Toxicol, 42(5), 2004, 725.